ONCOSIL MEDICAL
2004 - OncoSilTM was originally developed as BrachySilTM. pSivida grants exclusive worldwide royalty-bearing license agreement with Enigma Therapeutics for the development of BrachySil All preclinical and early phase clinical work conducted under sponsorship of pSivida February 2013 - Enigma Therapeutics was acquired by NeuroDiscovery Ltd June 2013 - NeuroDiscovery Ltd changed its name to OncoSil Medical Ltd and focused on developing OncoSilTM OncoSil Medical Ltd is an ASX-listed Medical Device Biotechnology Company headquartered in Sydney, Australia with global representation
ONCOSIL MEDICAL
Industry:
Medical Device Therapeutics
Address:
North Sydney, New South Wales, Australia
Country:
Australia
Status:
Active
Contact:
+61 2 9223 3344
Email Addresses:
[email protected]
Similar Organizations
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.